Establishing Buprenorphine for Acute Postoperative Pain Management
- 7 July 2025
- journal article
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 39 (4) , 555-566
Abstract
Opioids continue to be relied on to treat postoperative pain and continue to result in harms ranging from pruritis to overdose. The partial agonist opioid buprenorphine was synthesized in the 1960s as result of a search for a safe and effective opioid analgesic. While formulations of buprenorphine are approved for the treatment of pain, it is more commonly known as a medication for opioid use disorder. However, there is increasing interest in employing buprenorphine as a front-line perioperative opioid analgesic. We review the continued reliance on full agonist opioids and associated harms, highlight key efficacy and safety advantages of buprenorphine compared to usual care opioids, and describe the evolution of our consideration of buprenorphine for acute perioperative pain management. We then describe the process by which we worked within our institution to arrive at a twice daily buccal film and describe the clinical pathway ultimately implemented, providing details on training of staff, order set development, and surgical populations included. Buprenorphine presents a promising opportunity to reduce opioid harms while potentially improving pain outcomes after surgery. Our experience suggests that the buccal formulation possesses unique advantages for perioperative administration. Future directions will inform buprenorphine's impact on key pain and opioid-related outcomes.Keywords
This publication has 80 references indexed in Scilit:
- Association of Daily Doses of Buprenorphine With Urgent Health Care UtilizationJAMA Network Open, 2024
- Epidemiology of Opioid Prescribing After Discharge From Surgical Procedures Among AdultsJAMA Network Open, 2024
- Variation in Intraoperative Opioid Administration by Patient, Clinician, and Hospital ContributionJAMA Network Open, 2024
- Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 PandemicJAMA Network Open, 2023
- Association of Postsurgical Opioid Refills for Patients With Risk of Opioid Misuse and Chronic Opioid Use Among Family MembersJAMA Network Open, 2022
- Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 WaiverJAMA Network Open, 2022
- High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use DisorderJAMA Network Open, 2021
- Prevalence of Preoperative Opioid Use and Characteristics Associated With Opioid Use Among Patients Presenting for SurgeryJAMA Surgery, 2018
- New Persistent Opioid Use After Minor and Major Surgical Procedures in US AdultsJAMA Surgery, 2017
- Off-label Prescribing Among Office-Based PhysiciansArchives of internal medicine (1960), 2006